X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (298) 298
humans (269) 269
gastroenterology & hepatology (169) 169
male (142) 142
pharmacology & pharmacy (125) 125
female (124) 124
middle aged (111) 111
helicobacter pylori (109) 109
helicobacter infections - drug therapy (104) 104
adult (94) 94
drug therapy, combination (94) 94
treatment outcome (81) 81
infection (78) 78
aged (69) 69
omeprazole (64) 64
double-blind (63) 63
triple therapy (60) 60
eradication (59) 59
anti-bacterial agents - therapeutic use (54) 54
omeprazole plus amoxicillin (54) 54
proton pump inhibitors (54) 54
anti-ulcer agents - therapeutic use (48) 48
duodenal-ulcer (48) 48
efficacy (46) 46
plus omeprazole (46) 46
plus amoxicillin (43) 43
care and treatment (42) 42
clarithromycin (40) 40
medicine & public health (39) 39
metronidazole (39) 39
nonsteroidal antiinflammatory drugs (39) 39
anti-inflammatory agents, non-steroidal - adverse effects (38) 38
proton pump inhibitor (38) 38
omeprazole - therapeutic use (37) 37
therapy (36) 36
amoxicillin - therapeutic use (35) 35
helicobacter pylori - drug effects (35) 35
internal medicine (35) 35
lansoprazole (34) 34
prospective studies (33) 33
amoxicillin (32) 32
celecoxib (32) 32
medicine, general & internal (32) 32
recurrence (32) 32
animals (31) 31
peptic-ulcer (31) 31
anti-bacterial agents - administration & dosage (29) 29
anti-ulcer agents - administration & dosage (29) 29
drug therapy (29) 29
nonsteroidal anti-inflammatory drugs (29) 29
video capsule endoscopy (29) 29
analysis (28) 28
clarithromycin - therapeutic use (28) 28
clinical trials (28) 28
drug administration schedule (28) 28
duodenal ulcer - drug therapy (27) 27
abridged index medicus (26) 26
drug interactions (26) 26
oncology (26) 26
antibiotics (25) 25
capsule endoscopy (25) 25
cure (25) 25
adolescent (24) 24
health aspects (24) 24
hepatitis c (24) 24
pharmacokinetics (24) 24
amoxicillin - administration & dosage (23) 23
duodenal ulcer - microbiology (23) 23
omeprazole - administration & dosage (23) 23
rheumatoid-arthritis (23) 23
dosage and administration (22) 22
peptic-ulcer disease (22) 22
quadruple therapy (22) 22
clarithromycin - administration & dosage (21) 21
double-blind method (21) 21
dual therapy (21) 21
microbiology (21) 21
penicillins - therapeutic use (21) 21
pharmacology/toxicology (21) 21
randomized controlled trial (21) 21
aged, 80 and over (20) 20
antiviral agents - therapeutic use (20) 20
disease (20) 20
mucosal injury (20) 20
ranitidine bismuth citrate (20) 20
research (20) 20
risk factors (20) 20
bismuth - therapeutic use (19) 19
combination (19) 19
drugs (19) 19
patients (19) 19
pharmacotherapy (19) 19
review (19) 19
toxicology (19) 19
2-pyridinylmethylsulfinylbenzimidazoles (18) 18
endoscopy (18) 18
helicobacter infections - microbiology (18) 18
hepatitis c, chronic - drug therapy (18) 18
intestinal mucosa - pathology (18) 18
omeprazole - analogs & derivatives (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9736, pp. 173 - 179
Summary Background Cyclo-oxygenase (COX)-2-selective non-steroidal anti-inflammatory drugs (NSAIDs) and non-selective NSAIDs plus a proton-pump inhibitor (PPI)... 
Internal Medicine | GASTROINTESTINAL TOXICITY | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | MUCOSAL INJURY | OARSI RECOMMENDATIONS | RISK | NAPROXEN | PLUS OMEPRAZOLE | KNEE OSTEOARTHRITIS | EVIDENCE-BASED RECOMMENDATIONS | Lower Gastrointestinal Tract - drug effects | Osteoarthritis - ethnology | Humans | Middle Aged | Peptic Ulcer - prevention & control | Male | Osteoarthritis - drug therapy | Cyclooxygenase 2 Inhibitors - adverse effects | Arthritis, Rheumatoid - drug therapy | Adult | Female | Drug Therapy, Combination | Pyrazoles - adverse effects | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Diclofenac - adverse effects | Risk Factors | Treatment Outcome | Celecoxib | Pyrazoles - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Upper Gastrointestinal Tract - drug effects | Arthritis, Rheumatoid - ethnology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Sulfonamides - adverse effects | Diclofenac - administration & dosage | Peptic Ulcer - chemically induced | Research Design | Sulfonamides - administration & dosage | Omeprazole | Rheumatoid arthritis | Dosage and administration | Research | Comparative analysis | Drug therapy | Diclofenac | Heart failure | Likert scale | Inflammatory bowel disease | Arthritis | Clinical medicine | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Chemical Thermodynamics, ISSN 0021-9614, 03/2016, Volume 94, pp. 177 - 185
Data on corresponding (solid + liquid) equilibrium of omeprazole in different solvents are essential for a preliminary study of industrial applications. In... 
Omeprazole | Apelblat model | Thermodynamic parameters | CNIBS/R–K | Jouyban–Acree model | CNIBS/R-K | Jouyban-Acree model | PLUS WATER | METHANOL | ACID | ACETONE | CHEMISTRY, PHYSICAL | THERMODYNAMICS | TEMPERATURES | EQUILIBRIUM | ETHANOL | Thermodynamics | Chemical properties | Analysis
Journal Article
Journal of Gastroenterology, ISSN 0944-1174, 7/2011, Volume 46, Issue 7, pp. 894 - 905
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Research in Pharmaceutical Sciences, 07/2011, Volume 2, Issue 3, pp. 404 - 408
Journal Article
Alimentary Pharmacology and Therapeutics, ISSN 0269-2813, 01/2008, Volume 27, Issue 2, pp. 146 - 154
Journal Article